Gsa Capital Partners LLP Agenus Inc Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$0.53 - $0.93 $598,225 - $1.05 Million	-1,128,728 Reduced 47.04%	1,271,004 $737,000
Q4 2023 Feb 16, 2024	BUY	$0.63 - $1.14 $1.44 Million - $2.6 Million	2,279,243 Added 1891.66%	2,399,732 $1.99 Million
Q3 2023 Nov 15, 2023	BUY	$1.12 - $1.88 $86,408 - $145,042	77,150 Added 178.02%	120,489 $136,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $382,869 - $596,224	-292,267 Reduced 87.09%	43,339 $69,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $296,406 - $603,033	204,418 Added 155.82%	335,606 $510,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $213,271 - $343,135	105,580 Added 412.29%	131,188 $315,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $49,944 - $80,013	-25,482 Reduced 49.88%	25,608 $52,000
Q2 2022 Aug 09, 2022	SELL	$1.3 - $2.64 $25,004 - $50,777	-19,234 Reduced 27.35%	51,090 $99,000
Q1 2022 May 11, 2022	SELL	$2.35 - $3.47 $195,007 - $287,947	-82,982 Reduced 54.13%	70,324 $173,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $4,099 - $8,058	1,404 Added 0.92%	153,306 $494,000
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $684,774 - $911,658	137,505 Added 955.09%	151,902 $797,000
Q2 2021 Aug 05, 2021	BUY	$2.56 - $5.49 $6,868 - $14,729	2,683 Added 22.9%	14,397 $79,000
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $31,510 - $61,498	11,714 New	11,714 $32,000
Q2 2020 Aug 11, 2020	SELL	$2.29 - $4.24 $159,777 - $295,833	-69,772 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.92 - $4.39 $133,962 - $306,299	69,772 New	69,772 $171,000
Q2 2018 Aug 09, 2018	SELL	$2.26 - $4.65 $31,413 - $64,635	-13,900 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.51 - $6.04 $2,106 - $3,624	600 Added 4.51%	13,900 $65,000
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $43,358 - $63,574	13,300	13,300 $43,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account